Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Hussain Muhammad Raghib
   2. Issuer Name and Ticker or Trading Symbol
MARVELL TECHNOLOGY GROUP LTD [MRVL] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP Chief Strategy Officer
(Last)
(First)
(Middle)
C/O 5488 MARVELL LANE		 3. Date of Earliest Transaction (Month/Day/Year)
07/06/2018
(Street)

SANTA CLARA, CA 95054		 4. If Amendment, Date Original Filed(Month/Day/Year)
07/12/2018		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common shares 07/06/2018   A   697,698 (1) A (1) 697,698 (2) (3) D  
Common shares 07/06/2018   A   78,325 (4) A (4) 78,325 (3) I By family trusts (5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) $ 9.33 07/06/2018   A   40,339   07/06/2018 03/22/2020 Common shares 40,339 (6) 40,339 D  
Stock option (right to buy) $ 9.38 07/06/2018   A   100,848   07/06/2018 02/07/2021 Common shares 100,848 (6) 100,848 D  
Stock option (right to buy) $ 15.58 07/06/2018   A   51,981     (7) 02/16/2022 Common shares 51,981 (6) 51,981 D  
Stock option (right to buy) $ 12.12 07/06/2018   A   145,952     (8) 02/11/2023 Common shares 145,952 (6) 145,952 D  
Stock option (right to buy) $ 16.31 07/06/2018   A   116,024     (9) 02/10/2024 Common shares 116,024 (6) 116,024 D  
Restricted stock units (10) 07/06/2018   A   12,455 (11)     (12)   (12) Common shares 12,455 (13) 12,454 D  
Restricted stock units (10) 07/06/2018   A   18,887 (14)     (15)   (15) Common shares 18,887 (13) 18,886 D  
Restricted stock units (10) 07/06/2018   A   12,995 (16)     (17)   (17) Common shares 12,995 (13) 12,995 D  
Restricted stock units (10) 07/06/2018   A   41,106 (18)     (15)   (15) Common shares 41,106 (13) 41,105 D  
Restricted stock units (10) 07/06/2018   A   49,601 (19)     (20)   (20) Common shares 49,601 (13) 49,601 D  
Restricted stock units (10) 07/06/2018   A   65,076 (21)     (22)   (22) Common shares 65,076 (13) 65,075 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Hussain Muhammad Raghib
C/O 5488 MARVELL LANE
SANTA CLARA, CA 95054		       EVP Chief Strategy Officer  

Signatures

 M. Raghib Hussain by Blair Walters as attorney-in-fact   11/05/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Received in exchange for 228,698 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
(2) Includes shares which were deemed to be beneficially held by the Reporting Person in connection with the Merger previously reported on Table II.
(3) Correction to number of shares beneficially held directly and indirectly in Table I as reported.
(4) Received in exchange for 36,000 shares of Cavium, Inc. common stock in connection with the Merger. On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
(5) Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family.
(6) Received in the Merger in exchange for employee stock options to acquire shares of Cavium, Inc. stock.
(7) 4,331 options shall become exercisable in equal monthly installments on the 16th of each month beginning 7/16/18 and ending 2/16/2019.
(8) 30,407 options shall become exercisable in equal monthly installments on the 11th of each month beginning 7/11/2018 and ending 2/11/2020.
(9) 38,675 options shall become exercisable in equal monthly installments on the 10th of each month beginning 7/10/2018 and ending 2/10/2021.
(10) Each restricted stock unit represents a contingent right to receive one Marvell common share upon vesting.
(11) Received in exchange for restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger the Reporting Person acquired 12,455 Restricted Stock Units "RSUs".
(12) This award vests as to 100% of the shares on January 31, 2019.
(13) Received in the Merger in exchange for restricted stock units of Cavium, Inc.
(14) Received in exchange for restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger the Reporting Person acquired 18,887 RSUs.
(15) This award vests as to 50% of the shares on each of January 31, 2019 and 2020.
(16) Received in exchange for restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger the Reporting Person acquired 12,995 RSUs.
(17) This award vests as to 100% of the shares on January 31, 2019.
(18) Received in exchange for restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger the Reporting Person acquired 41,106 RSUs.
(19) Received in exchange for restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger the Reporting Person acquired 49,601 RSUs.
(20) This award vests as to 1/3 of the shares on each of January 31, 2019, 2020 and 2021.
(21) Received in exchange for restricted stock units of Cavium, Inc. in connection with the Merger. On the effective date of the Merger the Reporting Person acquired 65,076 RSUs.
(22) This award vests as of 25% of the shares on each of January 31, 2019, 2020, 2021 and 2022.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.